Headline is as follows; One dose of myostatin inhibitor bimagrumab results in permanent muscle mass increase
and, while there is a touch of sensationalism in there, the hype is rather justified.
"People with type-2 diabetes can build up a couple of kilos of muscle mass and lose a couple of kilos of fat, without training or changing their diet, by taking a one-time dose of the myostatin inhibitor bimagrumab. A study by researchers at Novartis has shown this to be the case."
Ergo-log link:
https://www.ergo-log...bimagrumab.html
For some background, the drug works through the follistatin pathway and had previously failed a 2016 study. The most recent work was just completed like 3 weeks ago:(Phase 2)
https://jamanetwork....article/2774903
In this newly completed study,, the drug was repositioned for Type 2 Diabetes and Obesity...
Can this be custom made? It is a monoclonal antibody; would that mean it would not be feasible to custom-produce it in small quantities or has technology advanced to the point that we can even obtain these items?